Literature DB >> 10685659

Renal cell carcinoma: current status and future plans.

R A Figlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10685659

Source DB:  PubMed          Journal:  Cancer J Sci Am        ISSN： 1081-4442


× No keyword cloud information.
  3 in total

1.  Combined cytoreductive laser therapy and immunotherapy for palliation of metastatic renal cell carcinoma to the head and neck.

Authors:  M B Paiva; J A Sercarz; A J Pantuck; M Polyakov; R A Figlin; R F Canalis; D J Castro
Journal:  Lasers Med Sci       Date:  2007-01-12       Impact factor: 3.161

2.  Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas.

Authors:  J D Kelly; J Dai; P Eschwege; J S Goldberg; B P Duggan; K E Williamson; N H Bander; D M Nanus
Journal:  Br J Cancer       Date:  2004-07-05       Impact factor: 7.640

Review 3.  γδ T cells for cancer immunotherapy: A systematic review of clinical trials.

Authors:  Jonathan Ph Fisher; Jennifer Heuijerjans; Mengyong Yan; Kenth Gustafsson; John Anderson
Journal:  Oncoimmunology       Date:  2014-01-17       Impact factor: 8.110
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.